[Federal Register Volume 85, Number 148 (Friday, July 31, 2020)]
[Notices]
[Page 46141]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16585]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Emergency Awards: Rapid 
Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 
(SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21, R01 
Clinical Trials Not Allowed).
    Date: August 21, 2020.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Chelsea D. Boyd, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892-9834, 301-761-6664, [email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Emergency Awards: Rapid 
Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 
(SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21, R01 
Clinical Trials Not Allowed).
    Date: August 26, 2020.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G41B, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Brenda Lange-Gustafson, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G41B, 
Bethesda, MD 20892-9834, (240) 669-5047, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 27, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-16585 Filed 7-30-20; 8:45 am]
BILLING CODE 4140-01-P